3-HYDROXY-3-METHYLGLUTARYL COENZYME-A REDUCTASE INHIBITOR IMPAIRS CELL-DIFFERENTIATION IN CULTURED ADIPOGENIC CELLS (3T3-L1)
Citation
E. Nishio et al., 3-HYDROXY-3-METHYLGLUTARYL COENZYME-A REDUCTASE INHIBITOR IMPAIRS CELL-DIFFERENTIATION IN CULTURED ADIPOGENIC CELLS (3T3-L1), European journal of pharmacology, 301(1-3), 1996, pp. 203-206
Categorie Soggetti
Pharmacology & Pharmacy
SICI code
0014-2999(1996)301:1-3<203:3CRIIC>2.0.ZU;2-P
Abstract
Lovastatin, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibito
r, inhibits the synthesis of mevalonic acid. We examined the effect of
lovastatin on the differentiation of the fibroblast/adipocyte cell li
ne (3T3-L1). Lovastatin inhibits the differentiation of 3T3-L1 cells i
n a dose-dependent fashion. The inhibitory effect of lovastatin was pa
rtially reversed by adding exogenous mevalonic acid to the 3T3-L1 cell
s. Exogenous cholesterol (15 mu g/ml) did not prevent lovastatin inhib
ition of adipocyte conversion. The isoprenoids, farnesol and geraniol,
partially prevented lovastatin inhibition of adipocyte conversion but
squalene did not prevent lovastatin inhibition of adipocyte conversio
n. We conclude that the inhibitory effect of lovastatin was partially
due to the blockade of the pathway leading to synthesis of isoprenoids
, which are downstream products of mevalonic acid.